Come up with a name for your new list and we'll add to it:
CureVac raised a round of funding on February 13, 2018. Investors include
Bill & Melinda Gates Foundation.
CureVac, a German clinical stage biopharmaceutical company founded in 2000, is pioneering the field of mRNA-based technology platforms for medical purposes, in which unmodified mRNA is specifically op…